In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics

In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics
Scientists question justification for the emergency authorization and worry about its effects on clinical trials of other possible treatments

Source Latest News from Science Magazine
Read more In FDA’s green light for treating COVID-19 with plasma, critics see thin evidence—and politics
August 24, 2020 at 04:00PM